[HTML][HTML] Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter's and Gitelman's Syndromes
L Sgarabotto, V Ravarotto, LF Stefanelli, M Cacciapuoti… - Antioxidants, 2023 - mdpi.com
Two human genetic tubulopathies, Bartter's (BS) and Gitelman's (GS) syndromes, have
normo/hypotension and absent cardiac remodeling despite their apparent angiotensin …
normo/hypotension and absent cardiac remodeling despite their apparent angiotensin …
Gitelman's and Bartter's syndromes: From genetics to the molecular basis of hypertension and more
V Ravarotto, G Bertoldi, LF Stefanelli… - Kidney and Blood …, 2022 - karger.com
Abstract Background: Gitelman's and Bartter's syndromes (GS/BS) are rare genetic
tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin …
tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin …
Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling
Abstract Background. Bartter's and Gitelman's syndromes (BS/GS) have a blunted Gq
protein-mediated cell signalling despite high circulating angiotensin II (Ang II) levels. This is …
protein-mediated cell signalling despite high circulating angiotensin II (Ang II) levels. This is …
Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans
Reactive oxygen species (ROS) are intermediates in reduction–oxidation reactions that
begin with the addition of one electron to molecular oxygen, generating the primary ROS …
begin with the addition of one electron to molecular oxygen, generating the primary ROS …
Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension …
LA Calò, G Maiolino - Journal of Endocrinological Investigation, 2015 - Springer
Abstract Introduction Extensive studies using Bartter's/Gitelman's syndrome patients have
provided insights into the angiotensin II (Ang II) signaling pathways involved in the …
provided insights into the angiotensin II (Ang II) signaling pathways involved in the …
[HTML][HTML] Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their “pH” …
Gitelman's syndrome (GS) and Bartter's syndrome (BS) are rare inherited salt-losing
tubulopathies whose variations in genotype do not correlate well with either clinical course …
tubulopathies whose variations in genotype do not correlate well with either clinical course …
Angiotensin II and cardiovascular-renal remodelling in hypertension: insights from a human model opposite to hypertension
V Ravarotto, E Pagnin, A Fragasso, G Maiolino… - High Blood Pressure & …, 2015 - Springer
Insights into the Angiotensin II (Ang II) signalling pathways have been provided by extensive
studies using Bartter's/Gitelman's syndromes patients. These syndromes are characterized …
studies using Bartter's/Gitelman's syndromes patients. These syndromes are characterized …
Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome
In a recent article, Wolfrum et al1 have shown that in human cells in culture, inhibition of Rho
kinase (RKO) activates Akt pathway, which they contend leads to cardiovascular protection …
kinase (RKO) activates Akt pathway, which they contend leads to cardiovascular protection …
Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling
Objective Angiotensin II (Ang II)-mediated activation of Rho kinase (ROK) is involved in the
pathophysiology of hypertension and cardiovascular remodeling. ROK also controls …
pathophysiology of hypertension and cardiovascular remodeling. ROK also controls …
Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways
LA Calò, M Puato, S Schiavo, M Zanardo… - Nephrology Dialysis …, 2008 - academic.oup.com
Abstract Background. Angiotensin II (Ang II) is a powerful proinflammatory cytokine and
growth factor that activates NF-κB, as well as NAD (P) H oxidase, and thus is a key factor for …
growth factor that activates NF-κB, as well as NAD (P) H oxidase, and thus is a key factor for …